Key facts
- Premaz’s last known valuation is $2.4M (Feb 2026).
- It has raised $460K; the latest was Seed Round ($460K) in Feb 2026.
- Notable investors include SFC Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Premaz
- ·The full record, as it builds
Funding rounds
No funding rounds for Premaz are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Premaz
Developer of an artificial intelligence-based cognitive testing infrastructure designed to detect early signs of memory decline. The company's platform delivers mobile assessments, generates detailed data on memory fidelity, applies algorithms for subtle cognitive change detection, and provides secure dashboards for tracking, enabling clinics, researchers, and trial operators to monitor brain health, identify deterioration, evaluate interventions, and support dementia and Alzheimer's research with standardized methods.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 3
- Website
- premaz.co.uk/
- Ownership
- Privately Held (backing)
Premaz doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Premaz shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Premaz in its N-PORT filings yet. We sweep new filings monthly.